EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers

Tomas Goncalves, Siobhan Cunniffe, Tiffany S Ma, Natalie Mattis, Andrew W Rose, Thomas Kent, David R Mole, Helene E B Geiller, Linda van Bijsterveldt, Timothy C Humphrey iD, Ester M Hammond iD, Richard J Gibbons und 2 weitere

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Tomas Goncalves und 13 weiteren Autor:innen. Beteiligte Einrichtung: MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK. Hauptthemen laut MEDLINE: Reactive Oxygen Species, X-linked Nuclear Protein, Telomere Homeostasis, Glioma. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health and Care Research Clinical Lectureship, MRC DPhil Studentship, HSRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The alternative lengthening of telomeres (ALT) pathway is a telomerase-independent mechanism for immortalization in cancer cells and is commonly activated in low-grade and high-grade glioma, as well as osteosarcoma. The ALT pathway can be activated under various conditions and has often been shown to include mutational loss of ATRX. However, this is insufficient in isolation and so other cellular event must also be implicated. It has been shown that excessive accumulation of DNA:RNA hybrid structures (R-loops) and/or formation of DNA–protein crosslinks (DPCs) can be other important driving factors. The underlying cellular events leading to R-loop and DPC formation in ALT cancer cells to date remain unclear. Here, we demonstrate that excessive cellular reactive oxygen species (ROS) is an important causative factor in the evolution of ALT-telomere maintenance in ATRX-deficient glioma. We identified three sources of elevated ROS in ALT-positive gliomas: co-mutation of SETD2, downregulation of DRG2, and hypoxic tumour microenvironment. We demonstrate that elevated ROS leads to accumulation of R-loops and, crucially, resolution of R-loops by the enzyme RNase H1 prevents ALT pathway activity in cells exposed to elevated ROS. Further, we found a possible causal link between the formation of R-loops and the accumulation of DPCs, in particular, formation of TOP1 complexes covalently linked to DNA (Top1cc). We also demonstrate that elevation of ROS can trigger over-activity of the ALT pathway in osteosarcoma and glioma cell lines, resulting in excessive DNA damage and cell death. This work presents important mechanistic insights into the endogenous origin of excessive R-loops and DPCs in ALT-positive cancers, as well as highlighting potential novel therapeutic approaches in these difficult-to-treat cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesX-linked Nuclear ProteinTelomere HomeostasisGliomaTelomereHumansCell Line, TumorR-Loop StructuresHistone-Lysine N-MethyltransferaseTumor MicroenvironmentMutation

Substanzen

Reactive Oxygen SpeciesX-linked Nuclear ProteinATRX protein, humanHistone-Lysine N-Methyltransferase

Autor:innen und Institutionen

  • MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Department of Paediatrics, University of Oxford, Oxford, OX3 9DU, UK.
  • Department of Physics, Faculty of Natural Sciences, Imperial College, London, SW7 2BW, UK.
  • Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7BN, UK.

ORCID-Profile: Timothy C Humphrey, Ester M Hammond, Anna M Rose

Förderung

  • National Institute of Health and Care Research Clinical Lectureship
  • MRC DPhil Studentship
  • HSRD VA
  • Academy of Medical Sciences Starter
  • University of Oxford Medical Sciences
  • Children with Cancer UK
  • Cancer Research UK
  • EU Horizon Europe Research and Innovation program Cancer Mission 'HIT-GLIO'

Zitieren

APA

Goncalves, T., Cunniffe, S., Ma, T. S., Mattis, N., Rose, A. W., Kent, T., Mole, D. R., Geiller, H. E. B., van Bijsterveldt, L., Humphrey, T. C., Hammond, E. M., Gibbons, R. J., Clynes, D., & Rose, A. M. (2025). Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf061

Vancouver

Goncalves T, Cunniffe S, Ma TS, Mattis N, Rose AW, Kent T, et al. Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf061

BibTeX
@article{Goncalves2025,
  author = {Goncalves, Tomas and Cunniffe, Siobhan and Ma, Tiffany S and Mattis, Natalie and Rose, Andrew W and Kent, Thomas and Mole, David R and Geiller, Helene E B and van Bijsterveldt, Linda and Humphrey, Timothy C and Hammond, Ester M and Gibbons, Richard J and Clynes, David and Rose, Anna M},
  title = {Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf061}
}
Kostenlos starten →